|
| |
| | | 56239 | | 21.04.2005 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 07.15. | | | | 07.15. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Certican 0.25 mg | dispergierbare Tabletten | Dispersible Tablets (Everolimus 0.25 mg) | L04AA18 | CI | | 02 | Certican 0.1 mg | dispergierbare Tabletten | Dispersible Tablets (Everolimus 0.1 mg) | L04AA18 | CI |
|
|
|
